Please review the QC test results indicated by icon below as well as clone information before placing your order.

R-CaMP1.07

Genetically-encoded fluorescent calcium sensor cDNA, R-CaMP1.07.

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Terms and conditions set forth by the DEPOSITOR	In publishing research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the original publication designated by the DEPOSITOR (Ohkura, M. et al. PLos One 7 (7): e39933, 2012) and an acknowledgment to the DEPOSITOR are requested. The DEPOSITOR may request the RECIPIENT to report on progress and/or results obtained through the use of the BIOLOGICAL RESOURCE, and the RECIPIENT shall respond truthfully to such a request by the DEPOSITOR. Any use of the BIOLOGICAL RESOURCE for profit purposes by the RECIPIENT, such as any use by for-profit entities, any use for the BIOLOGICAL RESOURCE by not-for-profit entities in researches funded in any part by or in collaboration with for-profit entities, or any use the BIOLOGICAL RESOURCE by the not-for-profit entities for patent filing or licensing, requires a separate license from the DEPOSITOR, prior to distribution.
Ordering	Please visit Information of Request for Distribution.[link]  Order form [Credit Card Payment]  [Bank Transfer Payment] This RESOURCE contains a fluorescent protein owned or licensed by Takara Bio USA, Inc. (TBUSA). Please refer to Clontech Limited Use Label License and use Exclusive MTA (download the LULL and the MTA [link]).
Remarks	This RESOURCE contains a fluorescent protein owned or licensed by Takara Bio USA, Inc. A part of license fees is required. This RESOURCE is not provided to for-profit organization or for for-profit research by non-profit organizations.

提供案内 (日本国内) [open/close]

提供条件	研究成果の公表にあたって寄託者の指定する文献(Ohkura, M. et al. PLos One 7 (7): e39933, 2012)を引用し、謝辞の表明を必要とする。寄託者は、利用の状況及び成果等について利用者に報告を求めることができ、利用者は誠実に寄託者の求めに対して回答することとする。当該リソースの営利目的での利用（営利団体による利用、非営利団体が営利団体から直接・間接を問わず資金等を受けて実施する研究、非営利団体と営利団体との共同研究、非営利団体による特許取得・ライセンス契約等の行為等）の希望については、事前に寄託者との間で、別途使用許諾に係る契約の締結が必要である。
提供依頼	手続きの詳細は、「提供申込みについて[link]」をご覧ください。 提供依頼書 [Word] Takara Bio USA, Inc.が保有している蛍光タンパク質を含みます。 Clontech Limited Use Label Licenseをご一読の上専用MTAの提出をお願いします (専用MTA (英語版のみ) とClontech Limited Use Label Licenseを入手[link])。
備考	Takara Bio USA, Inc.が保有している蛍光タンパク質を含みます。ライセンス料相当額を負担して頂きます。本件リソースは営利機関および非営利機関による営利目的研究には提供いたしません。

Please review the QC test results indicated by icon below as well as clone information before placing your order.

References and tips

Electronic file

Original reference

Further references such as user reports and related articles (go to bottom)

Featured content

Sequence information

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.

Test sheet	RDB14608_A7Bgp1-2.pdf

Nucleotide sequence of a portion of this resource (if available).

Primer: CMV-Forward Sequence file: RDB14608_A7Bga.seq
>D04021A3_A7Bg_1_CMV-Forward_C10_07_ABI24.ab1     1 TGGAACACTC CGCCCATTGA CGCAATGGGC GGTAGGCGTG TACGGTGGGA GGTCTATATA    61 AGCAGAGCTG GTTTAGTGAA CCGTCAGATC CGCTAGCGCT ACCGGACTCA GATCTCGCCA   121 CCATGGGTTC TCATCATCAT CATCATCATG GTATGGCTAG CATGACTGGT GGACAGCAAA   181 TGGGTCGGGA TCTGTACGAC GATGACGATA AGGATCTCGC CACCATGGTC GACTCATCAC   241 GTCGTAAGTG GAATAAGGCC GGTCACGCAG TCAGAGCTAT AGGTCGGCTG AGCTCACCCG   301 TGGTGTCCGA GCGGATGTAC CCCGAGGACG GCGCCCTGAA GAGCGAGATC AAGAAGGGCC   361 TGCGCCTGAA GGACGGCGGC CACTACGCCG CCGAGGTCAA GACCACCTAC AAGGCCAAGA   421 AGCCCGTGCA GCTGCCCGGC GCCTACATCG TGGACATCAA GTTGGACATC GTGTCCCACA   481 ACGAGGACTA CACCATCGTG GAACAGTGCG AACGCGCCGA GGGCCGCCAC TCCACCGGCG   541 GCATGGACGA GCTGTACAAG GGCGGTACCG GAGGGAGCCT GGTGAGCAAG GGCGAGGAGG   601 ACAACATGGC CATCATCAAG GAGTTCATGC GCTTCAAGGT GCACATGGAG GGCTCCGTGA   661 ACGGCCACGA GTTCGAGATC GAGGGCGAGG GCGAGGGCCG CCCCTACGAG GCCTTTCAGA   721 CCGCTAAGCT TGTCGTCGTT AAGGGTGGTC CTCTGCCCTT CGCCTGGGAC ATCCTGTCCC   781 CTCAGTTCAT GTACGGCTCC AAGGCCTACA TTAAGCACCC AGCCGACATC CCCGACTACT   841 TCAAGCTGTC CTTCCCCGAG GGCTTCAGGT GGGAGCGCGT GATGAACTTC GAGGACGGCG   901 GCATTATTCA CGTTAACCAG GACTCCTCCC TGCAAGACGG CGTGTTCATC TACAAGGTGA   961 AGCTGCGCGG CACCAACTTC CCCCCCCGAC GGCCCCGTAA TGCAGAGAGA CCATGGCTGG  1021 GAGGCCACGC GTGACCACTG ACTGAGAGCA GATCGCAGAT TAAGAGCCTT TCTCCTATTT 1081 GACAGACGGC ATGGACATTA CCACAACGAA GCTGGGGGAC GGGTTAT //
Primer: SV40polyA-R Sequence file: RDB14608_A7Bgb.seq
>D04021A3_A7Bg_1_SV40polyA-R_C11_08_ABI24.ab1     1 GAGGAGGGGA GTTTTAAGCA AGTAAAACCT CTACAAATGT GGTATGGCTG ATTATGATCT    61 AGAGTCGCGG CCGCTATGGG TTGGACTCCA CGTCTCCCGC CAACTTGAGA AGGTCAAAAT   121 TCAAAGTCTG TTTCACCGGG AATTCACCAC CACCACCACC ACCACTGCCT CCAGTCCCTC   181 CGCCCTTCGC TGTCATCATT TGTACAAACT CTTCGTAGTT TACCTGACCA TCCCCATCGA   241 TGTCTGCCAC CCTGATCATT TCATCAACCT CTTCATCTGT TAACTTCTCT CCAAGGTCTG   301 TCATCACGTG GCGAAGCTCT GCTGCGCCGA TGTAGCCATT GCCATCCTTA TCAAACACAC   361 GGAACGCTTC TCTAATTTCT TCTTCACTGT CTGTGTCGTT CATTTTTCTT GCCATCATTG   421 TCAGGAACTC AGGGAAGTCG AATGTGCCAT CACCGTCGGC ATCTACTTCA TTGATCATGT   481 CCTGCAGCTC TGCTTCTGTG GGGTTCTGCC CCAGAGACCG CATCACCGTC CCCAGCTCCT   541 TGGTTGTTAT TGTCCCATCC CCGTCCTTGT CAAATAGGGA GAAAGCCTCT TTAAATTCTG   601 CGATCTGCTC TTCAGTCAGT TGGTCACGCG TGGCCTCCCA GCCCATGGTC TTCTTCTGCA   661 TTACGGGGCC GTCGGGGGGG AAGTTGGTGC CGCGCAGCTT CACCTTGTAG ATGAACACGC   721 CGTCTTGCAG GGAGGAGTCC TGGTTAACGT GAATAATGCC GCCGTCCTCG AAGTTCATCA   781 CGCGCTCCCA CCTGAAGCCC TCGGGGAAGG ACAGCTTGAA GTAGTCGGGG ATGTCGGCTG   841 GGTGCTTAAT GTAGGCCTTG GAGCCGTACA TGAACTGAGG GGACAGGATG TCCCAGGCGA   901 AAGGGCAGAG GACCACCCTT AACGACGACA AGCTTAGCGG TCTGAAAGGC CTCGTAGGGG   961 CGGCCCTCGC CCTCGCCCTC GATCTCGAAC TCGTGGCCGT TCACGGAGCC CTCCATGTGC  1021 ACCTTGAGCG CATGACTCCT TGATGATGGC ATGTGTCTCT CGCCTGCTCA CAGCTCCTCG  1081 TACGCCTGTA CAGCTCGTCA TGCCGCGTGA ATGCCGTCCT CGGCGCGGTT CGCCACTGTT 1141 TTCCG //
Primer: SV40pro_F_V2 Sequence file: RDB14608_A7Bgc.seq
>D04021A3_A7Bg_1_SV40pro_F_V2_C12_09_ABI24.ab1     1 AGCAGAGCTT TTTTTGGAAG CCTAGGCTTT TGCAAGATCG ATCAAGAGAC AGGATGAGGA    61 TCGTTTCGCA TGATTGAACA AGATGGATTG CACGCAGGTT CTCCGGCCGC TTGGGTGGAG   121 AGGCTATTCG GCTATGACTG GGCACAACAG ACAATCGGCT GCTCTGATGC CGCCGTGTTC   181 CGGCTGTCAG CGCAGGGGCG CCCGGTTCTT TTTGTCAAGA CCGACCTGTC CGGTGCCCTG   241 AATGAACTGC AAGACGAGGC AGCGCGGCTA TCGTGGCTGG CCACGACGGG CGTTCCTTGC   301 GCAGCTGTGC TCGACGTTGT CACTGAAGCG GGAAGGGACT GGCTGCTATT GGGCGAAGTG   361 CCGGGGCAGG ATCTCCTGTC ATCTCACCTT GCTCCTGCCG AGAAAGTATC CATCATGGCT   421 GATGCAATGC GGCGGCTGCA TACGCTTGAT CCGGCTACCT GCCCATTCGA CCACCAAGCG   481 AAACATCGCA TCGAGCGAGC ACGTACTCGG ATGGAAGCCG GTCTTGTCGA TCAGGATGAT   541 CTGGACGAAG AGCATCAGGG GCTCGCGCCA GCCGAACTGT TCGCCAGGCT CAAGGCGAGC   601 ATGCCCGACG GCGAGGATCT CGTCGTGACC CATGGCGATG CCTGCTTGCC GAATATCATG   661 GTGGAAAATG GCCGCTTTTC TGGATTCATC GACTGTGGCC GGCTGGGTGT GGCGGACCGC   721 TATCAGGACA TAGCGTTGGC TACCCGTGAT ATTGCTGAAG AGCTTGGCGG CGAATGGGCT   781 GACCGCTTCC TCGTGCTTTA CGGTATCGCC GCTCCCGATT CGCAGCGCAT CGCCTTCTAT   841 CGCCTTCTTG ACGAGTTCTT CTGAGCGGGA CTCTGGGGTT CGAAATGACC GACCAAGCGA   901 CGCCCAACCT GCCATCACGA GATTTCGATT CCACCGCCGC CTTCTATGAA AGGTTGGGCT   961 TCGGAATCGT TTTCCCGGGA CGCCCGGCTG GATGATCCTC CCAGCGCGGG GGATCTCATG  1021 CTGGAGTTCT TCGCCCCACC CCTAAGGGGG AGGCTACTGA ACACGGAAGA GACAATTACT  1081 GATGACCGCG CTATGACGGC ATAAGACCGA TTAACGCACG ATGTGGGTCG TTTTGGTTTC 1141 CATAAAC //

Please visit Sequencing and PCR primers for primer information.

References

Original, user report and related articles

2022.05.17

GNP_filter3_RDBDEP_html_220516.pl